title: What's new in ventilator-associated pneumonia?
authors.affiliation: Vall d'Hebron Institut of Research, CIBERES, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. jrello@crips.es.
authors.forename: Jordi
authors.initials: J
authors.lastname: Rello
authors.affiliation: Vall d'Hebron Institut of Research, CIBERES, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
authors.forename: Jordi
authors.initials: J
authors.lastname: Riera
authors.affiliation: Department of Intensive Medicine, Hospital General Universitario de Alicante, Alicante, Spain.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Serrano
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality; D003937:Diagnosis, Differential; D017052:Hospital Mortality / Q000639:trends; D006801:Humans; D053717:Pneumonia, Ventilator-Associated / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D011159:Population Surveillance / Q000379:methods*; D012121:Respiration, Artificial / Q000009:adverse effects*; D047090:beta-Lactams / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams